The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(3-(3,4-dimethylphenyl)-4-(2-oxo-2H-chromen-3-yl)thiazol-2(3H)-ylidene)-2-oxo-2H-chromene-3-carbohydrazide ID: ALA4468410
Chembl Id: CHEMBL4468410
PubChem CID: 155533234
Max Phase: Preclinical
Molecular Formula: C30H21N3O5S
Molecular Weight: 535.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-n2c(-c3cc4ccccc4oc3=O)cs/c2=N/NC(=O)c2cc3ccccc3oc2=O)cc1C
Standard InChI: InChI=1S/C30H21N3O5S/c1-17-11-12-21(13-18(17)2)33-24(22-14-19-7-3-5-9-25(19)37-28(22)35)16-39-30(33)32-31-27(34)23-15-20-8-4-6-10-26(20)38-29(23)36/h3-16H,1-2H3,(H,31,34)/b32-30+
Standard InChI Key: VNENDSDPANZZAV-NHQGMKOOSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 535.58Molecular Weight (Monoisotopic): 535.1202AlogP: 5.28#Rotatable Bonds: 4Polar Surface Area: 106.81Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.89CX Basic pKa: ┄CX LogP: 5.71CX LogD: 5.71Aromatic Rings: 6Heavy Atoms: 39QED Weighted: 0.24Np Likeness Score: -1.14
References 1. Singh H, Singh JV, Bhagat K, Gulati HK, Sanduja M, Kumar N, Kinarivala N, Sharma S.. (2019) Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids., 27 (16): [PMID:31255497 ] [10.1016/j.bmc.2019.06.033 ]